US Patent 11767520 Compositions and methods for treating lung inflammation
Patent 11767520 was granted and assigned to aTyr Pharma on September, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+102 properties)
Article (+370 characters)
US Patent 11767520 Compositions and methods for treating lung inflammation
Article
Patent abstract
Provided are therapies, including combination therapies, for the treatment of lung inflammation, including interstitial lung diseases (ILDs), which include the use of at least one histidyl-tRNA synthetase (HRS) polypeptide or an expressible polynucleotide that encodes the HRS polypeptide, alone or in combination with at least one immunomodulatory agent.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
John D. Mendlein
Kathleen Ogilvie
Date of Patent
September 26, 2023
Patent Application Number
16499979
Date Filed
April 19, 2018
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11767520 Compositions and methods for treating lung inflammation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.